VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AXGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AXGNAxoGen, Inc.
$55.38$3.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAXGNCash Flow

AxoGen, Inc. (AXGN) Cash Flow Statement

30Y historyFree accessUpdated daily

Operating cash flow reached $16.5M and free cash flow $15.1M (a 20.0% margin) in 2026Q3, but quarterly OCF/net income ratios swing widely and stock-based compensation of $8.8M means cash conversion has not yet shown a consistent pattern.

Income StatementBalance SheetCash FlowRatios

AXGN Cash Flow Statement

Annual statement

AXGN Cash Flow Statement

AxoGen, Inc. (AXGN) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Cash from Operations22.63M812K4.54M-5.72M-16.07M-13.4M-9.63M-19.87M-17.86M-9.24M-11.2M-13.05M-10.45M-10.44M-8.66M-7.08M-2.43M15.44M-470.16K-466.95K-28.79K-709.62K878.84K-27.3K-755.02K-2.92M-1.27M-200K1.5M100K200K
Operating CF Margin %-0.36%2.42%-3.59%-11.59%-10.53%-8.57%-18.62%-21.28%-15.29%-27.26%-47.75%-62.14%-95.41%-112.61%-145.98%-2661.97%61.99%-646.62%-464.94%-22.73%-160.06%82.52%-0.38%-11.02%-18.35%-8.71%-1.63%11.63%0.81%1.53%
Operating CF Growth %379.04%-82.09%179.34%64.42%-19.85%-39.26%51.56%-11.25%-93.36%17.55%14.15%-24.89%-0.06%-20.58%-22.35%-191.37%-115.73%3384.37%-0.69%-1521.74%95.94%-180.74%3319.19%96.38%74.17%-129.83%-535.93%-113.33%1400%-50%100%
Net Income-31.92M-15.7M-9.96M-21.72M-28.95M-26.98M-23.79M-29.14M-22.4M-10.45M-14.41M-13.36M-17.71M-14.56M-9.42M-9.22M-1.32M15.05M-1.04M-748.98K-367.18K-530.61K-123.15K-1.28M-2.6M1.34M-2.86M-1.7M-400K-2.3M-600K
Depreciation & Amortization8.91M8.19M7.84M5.55M4.85M4.74M3.46M2.88M851K566.6K436.49K248.97K198.89K138.33K314.83K340.68K19.77K23.01K23.12K22.27K25.46K20.04K212.28K523.27K625.14K521.28K908.02K900K800K1M1.1M
Stock-Based Compensation41.01M30.11M15.91M14.42M15.59M10.92M8.47M10.3M7.61M3.61M1.39M1.32M956.45K671.89K495.08K250.04K245.26K0455.08K000000000000
Deferred Taxes000003.37M2.21M04.38M223.32K830.07K125.37K936.67K68.04K447.48K10.47M-586K48K00000000157K000-100K
Other Non-Cash Items12.73M2.83M797K415K2M831K232K1.53M81K246.56K2.05M589.56K5.28M3.96M1.3M-9.21M0-130K0332.93K31.65K86.78K2.04M52.38K27.11K-4.39M730K-100K100K2.3M0
Working Capital Changes-8.1M-24.62M-10.04M-4.39M-9.56M-6.28M-209K-5.45M-8.38M-3.44M-1.5M-1.98M-114.13K-728.44K-1.8M294.19K-792.39K454.6K92.34K-73.17K281.28K-285.83K-1.25M678.82K1.2M-400.38K-207.61K700K1M-900K-200K
Change in Receivables-3.28M-2.46M392K-2.69M-4.64M-499K-635K-2.14M-5.11M-3.24M-3.35M-2.04M-1.01M-902.23K-252.44K-368.95K000000000000000
Change in Inventory-8.48M-9.19M-10.16M-6.05M-3.66M-7.48M-910K-3.77M-6.01M-1.86M-1.52M-720.34K184.82K-247.33K-1.39M142.25K0000000-82.68K516.75K-177.65K-336.16K-300K900K-600K-300K
Change in Payables9.19M-7.16M125K6.51M660K-270K4.96M2.92M3.71M1.93M3.44M1.12M498.29K430.58K-105.35K0-22.35K58.5K12.75K000000000000
Cash from Investing-22.36M-5.32M-10.3M19.25M-3.2M-23.65M-16.96M27.27M-98.19M-1.29M-1.19M-555.52K-594.05K-243.97K-127.28K7.11M-2M-8.68K-29.91K00-60K862.68K773.09K-102.07K6.16M-563K-500K100K-300K-600K
Capital Expenditures-6.32M-3.75M-3.1M-13.87M-21.25M-28.4M-22.6M-4.66M-6.6M-1.29M-1.19M-555.52K-594.05K-243.97K-127.28K-89.47K-40.7K-8.68K-29.91K000-74.55K-22K-21.07K-371.91K-424.45K-400K-400K-200K-400K
CapEx % of Revenue2.37%1.66%1.66%8.72%15.34%22.3%20.12%4.37%7.87%2.14%2.89%2.03%3.53%2.23%1.65%1.84%44.59%0.03%41.14%---7%0.3%0.31%2.33%2.91%3.25%3.1%1.63%3.05%
Acquisitions00003.2M-589K692K0321K0000007.2M000000000000000
Investments-------------------------------
Other Investing-2.02M-1.85M-1.42M-1.05M-3.2M1.54M-692K-562K-321K-187K-226K-146.74K-52K-65.19K-78.83K000000-60K937.23K795.1K-81K6.53M-138.55K-100K-100K-100K-200K
Cash from Financing293.55M10.5M2.29M1.95M1.79M20.45M40.47M4.03M109.84M17.02M16.5M31.3M-808.85K16.85M14.51M6.36M-4.26M0018.09K0-159.12K13.96K-933.54K103.48K34.73K913.01K-500K-100K0300K
Debt Issued (Net)-92.11M-32K-10K-10K-12K14.98M34.99M29K-22.51M-21K-3.25M0-1.75M015.8M5.77M00000-2.52K-12.57K-936.73K101.2K07K859.42K000
Equity Issued (Net)368.07M10.53M2.3M1.96M1.81M5.47M3.5M0015.89M19.75M30.97M1.63M16.78M01M39K0018.09K06.45K8.75K3.19K2.27K028K53.59K-500K-200K0
Dividends Paid0000000000000000-4.3M0000-246.82K000000000
Share Repurchases0000000000000000000000000000-500K-200K-200K
Other Financing17.59M000001.99M4M132.35M1.15M0332.66K-684.6K73.33K-1.29M-408.29K0000083.78K17.78K0034.73K878.01K00100K0
Net Change in Cash293.82M5.99M-3.47M15.49M-17.47M-16.6M13.88M11.43M-6.21M6.49M4.1M17.69M-11.85M6.16M5.72M6.39M-8.69M15.43M-500.08K-448.86K-28.79K-928.74K1.76M-187.74K-753.62K3.28M-921.85K-1.2M1.5M-200K-100K
Free Cash Flow16.31M-2.93M11K-20.63M-37.32M-41.8M-32.22M-25.1M-24.46M-10.53M-12.39M-13.61M-11.05M-10.69M-8.79M-7.17M-2.47M15.43M-500.08K-466.95K-28.79K-709.62K804.29K-49.3K-776.09K-3.3M-1.7M-600K1.1M-100K-200K
FCF Margin %6.11%-1.3%0.01%-12.98%-26.93%-32.82%-28.69%-23.52%-29.15%-17.43%-30.15%-49.79%-65.68%-97.64%-114.27%-147.83%-2706.56%61.95%-687.76%-464.94%-22.73%-160.06%75.52%-0.68%-11.33%-20.69%-11.62%-4.88%8.53%-0.81%-1.53%
FCF Growth %471.75%-26763.64%100.05%44.71%10.73%-29.74%-28.39%-2.59%-132.34%15.04%8.92%-23.2%-3.33%-21.61%-22.6%-190.19%-116.01%3186.18%-7.09%-1521.74%95.94%-188.23%1731.38%93.65%76.45%-94.25%-182.72%-154.55%1200%50%85.71%
FCF per Share0.27-0.060.00-0.48-0.89-1.01-0.81-0.64-0.66-0.32-0.40-0.52-0.62-0.79-0.79-1.94-0.573.58-0.12-0.11-0.01-0.170.20-0.01-0.20-0.84-0.44-0.150.27-0.03-0.05
FCF Conversion (FCF/Net Income)-0.51x-0.05x-0.46x0.26x0.55x0.50x0.40x0.68x0.80x0.88x0.78x0.98x0.59x0.72x0.92x0.77x1.85x1.03x0.45x0.62x0.08x1.34x0.38x0.02x0.29x-2.18x0.44x0.12x-3.75x-0.04x-0.33x
Interest Paid000000034K00000000000000000000000
Taxes Paid0000000000000000000000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetAdequate
Cash FlowImproving
Top Statement Risk

Conversion gap persists

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Operating Cash Flow Diverges From Losses

As reported in financial statements, AXGN generated $16.5M of operating cash flow in 2026Q3 against net income of $2.3M, yet quarterly OCF/NI ratios swing from -0.99 to 13.35, making the conversion relationship difficult to read with confidence in any single period.

The most recent quarter shows operating cash flow well above reported earnings, which may reflect the $8.8M stock-based compensation add-back and a $3.3M working capital inflow rather than purely recurring cash generation. Negative net income in 2026Q1 and 2026Q2 alongside positive operating cash flow suggests non-cash charges are carrying much of the cash profile. Investors should monitor whether operating cash flow stays positive once SBC and working capital normalize.

Free Cash Flow Turns Positive Intermittently

Based on AXGN's reported figures, free cash flow reached $15.1M in 2026Q3, a 20.0% margin, after several quarters near breakeven or negative, indicating improvement that has not yet proven durable across consecutive periods.

Free cash flow margins moved from -27.7% in 2025Q1 to 20.0% in 2026Q3, but the path includes multiple negative quarters, including -2.0% in 2026Q1. The single strong quarter likely benefits from favorable working capital timing, so the underlying run-rate remains uncertain. Sustained margins above 10% over several quarters would be needed to support a structural improvement thesis.

Light Capital Intensity Despite Facility Transition

According to reported quarterly figures, AXGN's capital expenditures remained between 0.5% and 4.5% of revenue, with the Alachua facility transition not yet visible as a sustained spike in cash outflows.

Low capex intensity, with the 2026Q1 peak at 4.5% of revenue being the highest in the period, suggests the processing facility build has been largely absorbed by prior periods or is being funded through operating activity. Capex appears modest relative to D&A of $1.7M to $2.9M per quarter in recent periods, indicating maintenance-level spending. Warrants monitoring for whether the facility ramp requires higher reinvestment in coming quarters.

Working Capital Swings Drive Quarterly Volatility

Based on reported figures, AXGN's working capital changes ranged from a $5.6M outflow in 2025Q4 to a $3.3M inflow in 2026Q3, and these swings appear to account for a meaningful share of quarterly cash flow variability.

The alternation between working capital outflows and inflows is consistent with the stocking versus consignment dynamics noted in the business structure, which may create timing mismatches between revenue recognition and cash collection. Several large outflows coincided with periods of weaker operating cash flow, suggesting working capital drag has been a recurring source of cash pressure. Investors should watch inventory and receivables trends for a clearer underlying pattern.

Stock Compensation Masks Cash Burn

As reported in financial statements, AXGN's stock-based compensation of $6.8M to $16.6M per quarter is a large non-cash add-back, and without it several recent quarters would show materially weaker operating cash generation.

The cash flow statement adds back SBC, which may flatter operating cash flow relative to the economic cost borne by shareholders through dilution. In quarters such as 2025Q4 and 2026Q2, SBC exceeded operating cash flow, suggesting the business relies on equity compensation to retain talent. This framing suggests caution in treating reported operating cash flow as a clean measure of self-funded cash generation.

AXGN — Frequently Asked Questions

Quick answers to the most common questions about buying AXGN stock.

How much cash does AxoGen, Inc. (AXGN) generate from operations?

AxoGen, Inc. (AXGN) generated $0.8M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is AxoGen, Inc.'s free cash flow?

AxoGen, Inc. (AXGN) reported negative free cash flow of $2.9M in 2025, indicating capital requirements exceeded cash from operations.

What is AxoGen, Inc.'s capital expenditure (CapEx)?

AxoGen, Inc. (AXGN) spent $3.7M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.